Impaired Heart Rate Recovery Indices in Psoriasis Patients

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2014 Mar 4

PMID 24584215

Citations 4

Authors

Esra Pancar Yuksel

Serkan Yuksel

Mustafa Yenercag

Korhan Soylu

Fatma Aydin

Nilgun Senturk

Huriye Yucel

Tayyar Canturk

Ahmet Yasar Turanli

Affiliations

Soon will be listed here.

Abstract

Background: Psoriasis is a systemic inflammatory disease associated with increased risk of cardiovascular diseases. The heart rate recovery index (HRRI) is an indicator of autonomic nervous system function and is an independent prognostic risk factor for cardiovascular diseases. The aim of this study was to evaluate the heart rate recovery indices in patients with psoriasis.

Material And Methods: Thirty-three psoriasis patients (22 male; mean age 41 ± 11 years) and 26 healthy individuals (15 male; mean age 39 ± 11 years) as a control group were included in the study. Baseline electrocardiography, transthoracic echocardiographic examinations, and exercise stress tests were performed in psoriasis and control groups. The heart rate recovery of the psoriasis group at 1, 2, 3, 4, and 5 minutes after maximal exercise were calculated and compared to those of the control group.

Results: Baseline demographic and clinical characteristics of psoriasis and control groups including age, sex, body mass index, systolic blood pressure, and echocardiographic parameters were similar. Total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels were significantly higher and high-density lipoprotein cholesterol levels were significantly lower in the psoriasis group (p<0.05). Heart rate recovery at 1, 2, 3, 4, and 5 minutes after maximal exercise were found to be significantly lower in the psoriasis group (p<0.05). Additionally, baseline heart rates before exercise were significantly higher in the psoriasis group (p<0.05).

Conclusions: We found that impaired HRRI in psoriasis patients, which indicates the underlying autonomic nervous system dysfunction, is a pathophysiologic mechanism for increased cardiovascular disease risk.

Citing Articles

High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions.

Trakaki A, Marsche G Biomedicines. 2020; 8(12).

PMID: 33271807 PMC: 7760586. DOI: 10.3390/biomedicines8120558.

Cardiogoniometry in psoriatic patients and its comparison with a control group.

Poorzand H, Kiafar B, Asadzadeh Heravi F, Vejdanparast M, Saki A, Tayebi M Indian Heart J. 2017; 69(1):75-80.

PMID: 28228311 PMC: 5318983. DOI: 10.1016/j.ihj.2016.05.019.

Increased prevalence of early repolarization in electrocardiograms of psoriatic patients.

Mastrolonardo M, DArienzo G, Grimaldi M, Caivano M, Bonamonte D, Di Biase M Heart Vessels. 2015; 31(3):408-15.

PMID: 25549808 DOI: 10.1007/s00380-014-0619-z.

Smart multi-level tool for remote patient monitoring based on a wireless sensor network and mobile augmented reality.

Gonzalez F, Vergara Villegas O, Ramirez D, Cruz Sanchez V, Dominguez H Sensors (Basel). 2014; 14(9):17212-34.

PMID: 25230306 PMC: 4208221. DOI: 10.3390/s140917212.

References

Sommer D, Jenisch S, Suchan M, Christophers E, Weichenthal M . Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006; 298(7):321-8. DOI: 10.1007/s00403-006-0703-z. View

Pierpont G, Voth E . Assessing autonomic function by analysis of heart rate recovery from exercise in healthy subjects. Am J Cardiol. 2004; 94(1):64-8. DOI: 10.1016/j.amjcard.2004.03.032. View

FREDRIKSSON T, Pettersson U . Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 1978; 157(4):238-44. DOI: 10.1159/000250839. View

Sarli B, Dogan Y, Baktir A, Saglam H, Arinc H, Kurtul S . Heart rate recovery is impaired in patients with psoriasis. Med Princ Pract. 2013; 22:567-70. PMC: 5586797. DOI: 10.1159/000351884. View

COLE C, Blackstone E, Pashkow F, Snader C, Lauer M . Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999; 341(18):1351-7. DOI: 10.1056/NEJM199910283411804. View

Kremers H, McEvoy M, Dann F, Gabriel S . Heart disease in psoriasis. J Am Acad Dermatol. 2007; 57(2):347-54. DOI: 10.1016/j.jaad.2007.02.007. View

Shapiro J, Cohen A, David M, Hodak E, Chodik G, Viner A . The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2006; 56(4):629-34. DOI: 10.1016/j.jaad.2006.09.017. View

Ardic I, Gungor Kaya M, Yarlioglues M, Dogdu O, Celikbilek M, Akpek M . Assessment of heart rate recovery index in patients with familial Mediterranean fever. Rheumatol Int. 2010; 31(1):121-5. DOI: 10.1007/s00296-010-1550-y. View

Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F . Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001; 303(1-2):33-9. DOI: 10.1016/s0009-8981(00)00358-2. View

10.

Griffiths C, Barker J . Pathogenesis and clinical features of psoriasis. Lancet. 2007; 370(9583):263-271. DOI: 10.1016/S0140-6736(07)61128-3. View

11.

Bacaksiz A, Erdogan E, Sonmez O, Sevgili E, Tasal A, Onsun N . Ambulatory blood pressure monitoring can unmask hypertension in patients with psoriasis vulgaris. Med Sci Monit. 2013; 19:501-9. PMC: 3699538. DOI: 10.12659/MSM.889197. View

12.

Kaya E, Yorgun H, Akdogan A, Ates A, Canpolat U, Sunman H . Heart-rate recovery index is impaired in Behçet's disease. Tex Heart Inst J. 2009; 36(4):282-6. PMC: 2720298. View

13.

Menter A, Griffiths C, Tebbey P, Horn E, Sterry W . Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community. J Eur Acad Dermatol Venereol. 2010; 24(12):1371-7. DOI: 10.1111/j.1468-3083.2010.03656.x. View

14.

Dogdu O, Yarlioglues M, Gungor Kaya M, Ardic I, Oguzhan N, Akpek M . Deterioration of heart rate recovery index in patients with systemic lupus erythematosus. J Rheumatol. 2010; 37(12):2511-5. DOI: 10.3899/jrheum.100163. View

15.

Armstrong E, Harskamp C, Armstrong A . Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013; 2(2):e000062. PMC: 3647278. DOI: 10.1161/JAHA.113.000062. View

16.

Ahlehoff O, Gislason G, Charlot M, Jorgensen C, Lindhardsen J, Olesen J . Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med. 2010; 270(2):147-57. DOI: 10.1111/j.1365-2796.2010.02310.x. View

17.

Ardic I, Gungor Kaya M, Yarlioglues M, Dogdu O, Buyukoglan H, Kalay N . Impaired heart rate recovery index in patients with sarcoidosis. Chest. 2010; 139(1):60-8. DOI: 10.1378/chest.09-3022. View

18.

Arena R, Guazzi M, Myers J, Peberdy M . Prognostic value of heart rate recovery in patients with heart failure. Am Heart J. 2006; 151(4):851.e7-13. DOI: 10.1016/j.ahj.2005.09.012. View

19.

Singh G, Aneja S . Cardiovascular comorbiditiy in psoriasis. Indian J Dermatol. 2011; 56(5):553-6. PMC: 3221222. DOI: 10.4103/0019-5154.87154. View

20.

Imai K, Sato H, Hori M, Kusuoka H, Ozaki H, Yokoyama H . Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol. 1994; 24(6):1529-35. DOI: 10.1016/0735-1097(94)90150-3. View